• Mashup Score: 0

    Patients with COPD treated with inhaled corticosteroids for more than 6 months had a decreased risk for all-cause mortality, according to study results published in CHEST.Further, several demographic characteristics were identified as predictors of lower odds for mortality when receiving inhaled corticosteroids, according to researchers.

    Tweet Tweets with this article
    • Compared with inhaled therapy for patients with #COPD not containing inhaled #corticosteroids, researchers found a decreased risk for all-cause mortality linked to therapy with inhaled corticosteroids (Peto OR = 0.9). https://t.co/Gr2igoakKV

  • Mashup Score: 1

    Patients with COPD treated with inhaled corticosteroids for more than 6 months had a decreased risk for all-cause mortality, according to study results published in CHEST.Further, several demographic characteristics were identified as predictors of lower odds for mortality when receiving inhaled corticosteroids, according to researchers.

    Tweet Tweets with this article
    • According to study results published in @journal_CHEST, patients with #COPD treated with inhaled #corticosteroids for more than 6 months had a decreased risk for all-cause mortality. https://t.co/Gr2igoakKV